BIOMAT Database Logo BIOMAT Database Logo

Novel omega-3 agent reduces residually high triglyceride levels in patients treated with statins. 2012

Alexandra King

UI MeSH Term Description Entries

Related Publications

Alexandra King
Changes in triglyceride levels in ultra-high risk for psychosis individuals treated with omega-3 fatty acids.
February 2018, Early intervention in psychiatry,
Alexandra King
Serum triglyceride levels in patients treated with clozapine.
September 1996, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists,
Alexandra King
Omega 3 Fatty Acids Reduce the Triglyceride Levels in Rats with Apical Periodontitis.
January 2018, Brazilian dental journal,
Alexandra King
Using high-dose omega-3 fatty acid supplements to lower triglyceride levels in 10- to 19-year-olds.
May 2014, Clinical pediatrics,
Alexandra King
Trial watch: Antisense agent reduces LDL-cholesterol levels in high-risk patients.
January 2010, Nature reviews. Drug discovery,
Alexandra King
Combination therapy with statins and omega-3 fatty acids.
August 2006, The American journal of cardiology,
Alexandra King
Novel Omega-3 Fatty Acid Epoxygenase Metabolite Reduces Kidney Fibrosis.
May 2016, International journal of molecular sciences,
Alexandra King
Liraglutide reduces plasma PCSK9 in patients with type 2 diabetes not treated with statins.
March 2022, Diabetes & metabolism,
Alexandra King
Icosapent ethyl, a pure EPA omega-3 fatty acid: effects on lipoprotein particle concentration and size in patients with very high triglyceride levels (the MARINE study).
January 2012, Journal of clinical lipidology,
Alexandra King
Single-agent chemotherapy with docetaxel significantly reduces PSA levels in patients with high-grade localized prostate cancers.
January 2004, Urologia internationalis,
Copied contents to your clipboard!